Dorsata
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.0m | Convertible | ||
$1.1m | Seed | ||
$1.1m | Seed | ||
N/A | $2.0m | Seed | |
N/A | $2.4m | Early VC | |
* | $5.2m | Series A | |
N/A | Late VC | ||
Total Funding | AUD19.8m |
Recent News about Dorsata
EditDorsata is a healthcare technology company specializing in clinical decision support systems tailored for obstetrics and gynecology (OB-GYN) practices. The company operates in the healthcare technology market, serving medical professionals and healthcare providers who focus on women's health. Dorsata's core product, the ACOG Prenatal Record, integrates seamlessly with existing electronic health records (EHR) to provide real-time, evidence-based guidelines from the American College of Obstetricians and Gynecologists (ACOG). This system enhances the efficiency of OB-GYN workflows by automating routine tasks, improving diagnosis, treatment, and documentation processes. The platform is designed to be intuitive, requiring minimal training, and aims to maximize the time healthcare providers spend with patients while minimizing administrative overhead. Dorsata generates revenue through a subscription-based business model, charging healthcare providers for access to its advanced clinical decision support tools. The company also offers ancillary services and pathway guideline development to further support healthcare providers in delivering optimal patient care.
Keywords: OB-GYN, clinical decision support, EHR integration, ACOG guidelines, automated reporting, healthcare technology, prenatal care, workflow optimization, patient safety, subscription model.